New Delhi, February 11 The Supreme Court on Wednesday refused to restrain Zydus Lifesciences from selling its affordable, generic biosimilar of Nivolumab, a life-saving cancer drug registered by Bristol Myers Squibb (BMS).A bench of Chief Justice Surya Kant and Justice Joymalya Bagchi was...